Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-23-003471 General Corporate
Capex intensity 67th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.20% · OPTIONAL · VALID
Operating cash generation 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-355.17% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
50.22% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.40% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
23.44% · CORE · VALID
Operating margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-525.62% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
117.11% · OPTIONAL · VALID
SBC intensity 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 11.93%
Current 4.20%
Delta -7.73% Cash Generation Increased
Previous -836.49%
Current -355.17%
Delta 481.32% Growth Increased
Previous -75.35%
Current 50.22%
Delta 125.57% Inventory Pressure Increased
Previous 29.35%
Current 38.40%
Delta 9.06% Margin Increased
Previous 6.42%
Current 23.44%
Delta 17.02% Profitability Increased
Previous -1472.11%
Current -525.62%
Delta 946.48% R And D Intensity Decreased
Previous 299.87%
Current 117.11%
Delta -182.76% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.